Jennifer (Jen) Pardi, MBA was appointed Global Head of Equity Capital Markets in October 2020 and is responsible for oversight of Canaccord Genuity’s global ECM activities, with a focus on driving coordination and best practices across all regions to drive optimal outcomes for our corporate and institutional clients.
Jen joined Adams Harkness (acquired by Canaccord in 2005) in 2003. She has held roles of increasing responsibility within the U.S. ECM team and has been integral to increasing CG’s U.S. syndicate participation and subsequent advancement to a top-ranked midmarket investment dealer in the region. She was promoted to Head of U.S. Equity Capital Markets in September 2013. With extensive corporate finance, equity and debt capital markets experience, Jen has been at the forefront of Canaccord Genuity’s cross-border equity capital markets activities and has been involved in the completion of over 1,000 transactions with an aggregate value of over $150 billion.
Based in Boston, Jen also serves on Canaccord Genuity’s U.S. Operating Committee. She has been a significant contributor to CG’s firmwide diversity initiatives, with a strong focus on increasing opportunities for women entering the capital markets, in addition to driving CG’s participation in various local community and charitable initiatives.
Selected Transactions
-
US$30m
Sesen Bio Inc.
Sole Bookrunner (CMPO)
-
US$26m
Sharpspring
Joint Bookrunner (Secondary Public Offering)
-
US$17m
Better Choice Company
Lead Agent (Private Placement)
-
US$21m
KushCo. Holdings
Sole Agent (Private Placement)
-
US$53m
Cansortium Inc.
Co-Lead (IPO)
-
US$10m
SharpSpring
Sole Bookrunner (CMPO)
-
A$33m
Fluence
Lead Management (Placement)
-
US$17m
CPI AERO
Sole Bookrunner (Follow-On Offering)
-
US$78m
STAAR Surgical
Sole Bookrunning Manager (Bought Deal)